Skip to content

Public FDA record

Z-3089-2024: IBA Proton Therapy System - PROTEUS 235 ProteusPLUS and ProteusONE Software versions: PTS-8 versions, PT

Recall record Z-3089-2024 for Ion Beam Applications S.A.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-3089-2024
Company in FDA record
Ion Beam Applications S.A.
FDA classification date
Sep 10, 2024
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Safety Parameters Verification Mechanisms can be deactivated in clinical runtime

Source facts

Action
IBA issued AMENDED Urgent Medical Device Correction letter (IBA REFERENCE NCIPT-27531) on 7/10/24 provided by IBA directly to the customer either by hand or by email. Letter states reason for recall, health risk and action to take: Regarding Proteus 235 with a PTS-8, PTS-10, PTS-11 or PTS-12 versions: actions: Regarding the malfunction of Safety Parameters Verification Mechanism within BAPP . IBA carried out an analysis to determine if the impacted sites have some safety parameters checked by the BAPP in their clinical site configuration with values leading to violations. The result of this analysis showed that there are no sites with safety parameters checked by the BAPP out of tolerance. Regarding the possibility to disable a Safety Parameters Verification Mechanism (concerns PTS-8, PTS-10, PTS-11 or PTS-12 versions): IBA will carry out an analysis to determine if the impacted sites have specific configuration parameters that allow to deactivate the Safety Parameters Verification Mechanisms in the clinical configuration and if the case, remove them from the clinical site configuration. The result of the analysis will be provided to you on July 31, 2024, at the latest. Final solutions: Regarding the malfunction of Safety Parameters Verification Mechanism within BAPP (only concerns PTS-10, PTS-11 or PTS-12 versions): IBA will ensure that the system cannot be used in clinical with safety parameters checked by the BAPP out of tolerances. Regarding the possibility to disable a Safety Parameters Verification Mechanism (concerns PTS-8, PTS-10, PTS-11 or PTS-12 versions): IBA will ensure that the system displays a Red Banner informing the customer that the system must not be used for clinical activities when safety parameter Verification Mechanisms are deactivated to prevent the users from treating patients. The intermediate action will be implemented for your site by August 31, 2024, at the latest. The final solution will be implemented for your site by June 2026. Fi
Initiated
2024-07-08
Root cause
Under Investigation by firm
Distribution
Worldwide - US Nationwide distribution in the states of AK, NJ, PA, VA,OK,FL, KA, IL, LA, MI, TN , TX, VA and the countries of BE, CZ, DE, ES, FR, IN, IT, JP, NL, PL, RU, SE, SG, TW.
Recall number
Z-3089-2024
Recall status
Open, Classified
CDRH record ID
209418
FDA classified
2024-09-10
Recall event number
95080

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗